- Home
- BKD vs HROW Comparison
BKD vs HROW Comparison
Compare BKD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKD
- HROW
- Stock Information
- Founded
- BKD 2005
- HROW 1998
- Country
- BKD United States
- HROW United States
- Employees
- BKD N/A
- HROW N/A
- Industry
- BKD Hospital/Nursing Management
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- BKD Health Care
- HROW Health Care
- Exchange
- BKD Nasdaq
- HROW Nasdaq
- Market Cap
- BKD 1.7B
- HROW 1.4B
- IPO Year
- BKD 2005
- HROW N/A
- Fundamental
- Price
- BKD $7.68
- HROW $36.99
- Analyst Decision
- BKD Buy
- HROW Strong Buy
- Analyst Count
- BKD 5
- HROW 7
- Target Price
- BKD $7.80
- HROW $64.67
- AVG Volume (30 Days)
- BKD 2.7M
- HROW 671.8K
- Earning Date
- BKD 11-05-2025
- HROW 08-11-2025
- Dividend Yield
- BKD N/A
- HROW N/A
- EPS Growth
- BKD N/A
- HROW N/A
- EPS
- BKD N/A
- HROW N/A
- Revenue
- BKD $3,051,698,000.00
- HROW $227,661,000.00
- Revenue This Year
- BKD $8.33
- HROW $45.86
- Revenue Next Year
- BKD N/A
- HROW $41.41
- P/E Ratio
- BKD N/A
- HROW N/A
- Revenue Growth
- BKD 4.23
- HROW 47.69
- 52 Week Low
- BKD $4.45
- HROW $20.85
- 52 Week High
- BKD $8.01
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- BKD 55.28
- HROW 51.26
- Support Level
- BKD $7.57
- HROW $37.09
- Resistance Level
- BKD $7.77
- HROW $40.41
- Average True Range (ATR)
- BKD 0.19
- HROW 1.56
- MACD
- BKD 0.01
- HROW -0.33
- Stochastic Oscillator
- BKD 76.00
- HROW 28.60
About BKD Brookdale Senior Living Inc.
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.